ArticleJournal of translational medicine2023

Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.

Jaekwon Seok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.